FDA Drug Recalls

Recalls / Brands / Cisatracurium Besylate

Cisatracurium Besylate

4 FDA drug recalls involving brand “Cisatracurium Besylate” — 1 Class I.

DateClassProductFirm
2025-11-26Class IIICisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, SOMERSET THERAPEUTICS LLC
2025-11-26Class IIICisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, MSOMERSET THERAPEUTICS LLC
2025-11-26Class IIICisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx OnSOMERSET THERAPEUTICS LLC
2021-01-27Class ICisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packagMeitheal Pharmaceuticals Inc